The true impact of the French pay-for-performance program on physicians’ benzodiazepines prescription behavior

European Journal of Health Economics

Volumn 17, Issue 6, 2016, Pages 723-732

  Michel Lepage, Audrey ^a,c   Ventelou, Bruno ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c IHU   (France)

Author keywords

Behaviors; Benzodiazepines; CAPI; General practitioners; Pay for performance

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; CONTRACT; COST CONTROL; CROSS-SECTIONAL STUDY; FEMALE; FRANCE; GENERAL PRACTITIONER; HUMAN; LONGITUDINAL STUDY; MALE; MEDICAL FEE; MIDDLE AGED; PAY FOR PERFORMANCE PROGRAM; PRESCRIPTION; PRIORITY JOURNAL; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DRUG UTILIZATION; ECONOMICS; FACTUAL DATABASE; PERSONNEL MANAGEMENT; PHYSICIAN; PRACTICE GUIDELINE; PUBLIC HEALTH; REIMBURSEMENT; STATISTICS AND NUMERICAL DATA;

ADULT; BENZODIAZEPINES; CONTRACTS; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; FRANCE; GENERAL PRACTITIONERS; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PHYSICIAN INCENTIVE PLANS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTIONS; REIMBURSEMENT, INCENTIVE;

EID: 84939857269     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-015-0717-6     Document Type: Article

References (24)

1. Or, Z.: P4P for generalists: first results. IRDES, France (2010)
2. Bras, P.-L.: Le contrat d’amélioration des pratiques individuelles (CAPI) à la lumière de l’expérience anglaise. J. Déconomie Médicale 29(5), 216–230 (2011)
3. Roekeghem, F.V.: Pour une nouvelle dynamique collective de santé publique. Trib. Santé. no 35, 21–27 (2012)
4. Polton, D., Aubert, J.-M.: Le contrat d’amélioration des pratiques individuelles, aboutissement ou nouveau départ pour la gestion des soins? (2010), http://www.ces-asso.org/docs/Let_CES_3-2010.pdf. Accessed Sept 2010
5. Saint-Lary, O., Plu, I., Naiditch, M.: Adhérer ou pas au CAPI: de quel clivage des généralistes le paiement à la performance est-il le révélateur ? Rev. Fr. Aff. Soc. no 2–3, 180–209 (2011)
6. Bras, P.-L., Duhamel, G.: Rémunérer les médecins selon leurs performances: les enseignements des expériences étrangères. Inspection générale des affaires sociales, Paris (2008)
7. Mannion, R., Davies, H.: Payment for performance in health care. BMJ 336, 306–308 (2008)
8. Hahn, J.: Pay-for-performance in health care. CRS report for congress. The Library of Congress, Washington (2006)
9. Doran, T., Fullwood, C., Gravelle, H., Reeves, D., Kontopantelis, E., Hiroeh, U., Roland, M.: Pay-for-performance programs in family practices in the United Kingdom. N. Engl. J. Med. 355, 375–384 (2006)
10. Walker, S., Mason, A.R., Claxton, K., Cookson, R., Fenwick, E., Fleetcroft, R., Sculpher, M.: Value for money and the quality and outcomes framework in primary care in the UK NHS. Br. J. Gen. Pract. J. R. Coll. Gen. Pract. 60, e213–e220 (2010)
11. Lindenauer, P.K., Remus, D., Roman, S., Rothberg, M.B., Benjamin, E.M., Ma, A., Bratzler, D.W.: Public reporting and pay for performance in hospital quality improvement. N. Engl. J. Med. 356, 486–496 (2007)
12. ANSM: État des lieux de la consommation des benzodiazépines en France. Agence Nationale de Sécurité du Médicament (ANSM) (2013)
13. Insomnie, anxiété: consommation des benzodiazépines en hausse, http://www.leparisien.fr/laparisienne/sante/insomnie-anxiete-consommation-des-benzodiazepines-en-hausse-08-01-2014-3474243.php. Accessed 8 Jan 2014
14. Bernstein, D., Blotiere, P.-O., Bousquet, F., Legal, R., Silvera, L.: La variabilité des pratiques en médecine générale: une analyse sur données de l’Assurance-Maladie. CNAMTS (2012), http://www.ces-asso.org/sites/default/files/renaud.pdf. Accessed 8 Aug 2015
15. Heckman, J., Ichimura, H., Smith, J., Todd, P.: Characterizing selection bias using experimental data. Econometrica. 66, 1017–1098 (1998)
16. Angrist, J., Krueger, A.B.: Instrumental variables and the search for identification: from supply and demand to natural experiments. National Bureau of Economic Research, Cambridge (2001)
17. Heckman, J.: Instrumental variables. A study of implicit behavioral assumptions used in making program evaluations. J. Hum. Resour. 32, 441–462 (1997)
18. Alshamsan, R., Lee, J.T., Majeed, A., Netuveli, G., Millett, C.: Effect of a UK pay-for-performance program on ethnic disparities in diabetes outcomes: interrupted time series analysis. Ann. Fam. Med. 10, 228–234 (2012)
19. Campbell, S.M., Reeves, D., Kontopantelis, E., Sibbald, B., Roland, M.: Effects of pay for performance on the quality of primary care in England. N. Engl. J. Med. 361, 368–378 (2009)
20. Gravelle, H., Sutton, M., Ma, A.: Doctor behaviour under a pay-for-performance contract: treating, cheating and case finding?*. Econ. J. 120, F129–F156 (2010)
21. Saint-Lary, O., Sicsic, J.: Impact of a pay-for-performance programme on French GPs’ consultation length. Health Policy Amst, Neth (2014)
22. Hsieh, H.-M., Tsai, S.-L., Shin, S.-J., Mau, L.-W., Chiu, H.-C.: Cost-effectiveness of diabetes pay-for-performance incentive designs. Med. Care 53, 106–115 (2015)
23. Tan, E.C.-H., Pwu, R.-F., Chen, D.-R., Yang, M.-C.: Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan? Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil. 23, 687–696 (2014)
24. World Health Organization: Impact of a pay-for-performance programme on French GPs’ consultation length. World Health Organization, Geneva (2014)